Skip to main content

CORRECTION article

Front. Oncol., 24 August 2023
Sec. Molecular and Cellular Oncology
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1271492

Corrigendum: Multifunctions of CRIF1 in cancers and mitochondrial dysfunction

This article is a correction to:

  1. Multifunctions of CRIF1 in cancers and mitochondrial dysfunction

    1. Read original article
Yangzhou Jiang&#x;Yangzhou Jiang1†Yang Xiang&#x;Yang Xiang1†Chuanchuan LinChuanchuan Lin1Weiwei ZhangWeiwei Zhang1Zhenxing YangZhenxing Yang1Lixin XiangLixin Xiang1Yanni XiaoYanni Xiao1Li ChenLi Chen1Qian Ran*Qian Ran1*Zhongjun Li,*Zhongjun Li1,2*
  • 1Laboratory of Radiation Biology, Laboratory Medicine Center, Department of Blood Transfusion, The Second Affiliated Hospital, Army Military Medical University, Chongqing, China
  • 2State Key Laboratory of Trauma, Burn and Combined Injuries, The Second Affiliated Hospital, Army Medical University, Chongqing, China

A Corrigendum on
Multifunctions of CRIF1 in cancers and mitochondrial dysfunction

by Jiang Y, Xiang Y, Lin C, Zhang W, Yang Z, Xiang L, Xiao Y, Chen L, Ran Q and Li Z (2022). Front. Oncol. 12:1009948. doi: 10.3389/fonc.2022.1009948

In the published article, there was an error in the Funding statement. The number for the funding from Chongqing Science and Technology Commission was incorrectly displayed as “No. 2021C035”, the correct number is “cstc2021jcyj-jqX0004”. The correct Funding statement appears below.

FUNDING

This work was supported by projects of the International Cooperation and Exchanges NSFC (No. 82020108025), National Natural Science Foundation of China (No. 81972973), and Chongqing Science and Technology Commission (cstc2021jcyj-jqX0004).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: CR6-interacting factor 1, cell cycle regulation, cell proliferation regulation, cancer treatment, mitochondrial ribosomal protein, mitochondrial dysfunction

Citation: Jiang Y, Xiang Y, Lin C, Zhang W, Yang Z, Xiang L, Xiao Y, Chen L, Ran Q and Li Z (2023) Corrigendum: Multifunctions of CRIF1 in cancers and mitochondrial dysfunction. Front. Oncol. 13:1271492. doi: 10.3389/fonc.2023.1271492

Received: 02 August 2023; Accepted: 04 August 2023;
Published: 24 August 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Jiang, Xiang, Lin, Zhang, Yang, Xiang, Xiao, Chen, Ran and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Qian Ran, louise-r-q@163.com; Zhongjun Li, johnneyusc@gmail.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.